Despite there being no current existence of an effective treatment for the chronic progressive phase of Multiple Sclerosis, some sigificant findings were made by The Children’s Hospital Boston through experiments on mice. Researchers, however, cut the risk of nerve degeneration in mice with MS-type symptoms by giving them a form of vitamin B3 called nicotinamide. A spokesperson for the MS Trust said: “These are interesting results, but studies in mice with the experimental equivalent of MS may not necessarily translate into a successful treatment for people with MS.”